Blume Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$3.23M |
| 2 |
Wells Fargo
WFC
|
+$2.06M |
| 3 |
Apple
AAPL
|
+$1.07M |
| 4 |
Capital One
COF
|
+$735K |
| 5 |
iShares Biotechnology ETF
IBB
|
+$664K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MetLife
MET
|
+$582K |
| 2 |
GE Aerospace
GE
|
+$540K |
| 3 |
Johnson & Johnson
JNJ
|
+$528K |
| 4 |
Microsoft
MSFT
|
+$299K |
| 5 |
VanEck Oil Services ETF
OIH
|
+$134K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.74% |
| 2 | Energy | 16.36% |
| 3 | Healthcare | 12.23% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 11.1% |
Similar funds
Blume Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, Blume Capital Management held 263 positions worth $152M, up 4.7% from $145M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Blume Capital Management deployed $6.36M of net new capital in Q2 2016, opening 17 new positions and adding to 37 existing holdings. Its largest new stake was State Street SPDR Nuveen ICE Municipal Bond ETF: 1,536 shares worth $78K.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was MetLife, an estimated $582K trimmed.
- Blume Capital Management's largest Q2 2016 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 1,536 shares worth $78K.
- Blume Capital Management added most to Allergan plc in Q2 2016, an estimated $3.23M increase.
- Blume Capital Management's biggest Q2 2016 reduction was MetLife, cutting an estimated $582K.
- Blume Capital Management fully exited VanEck Oil Services ETF in Q2 2016, selling an estimated $134K.
- Blume Capital Management's ten largest holdings make up 46% of its $152M portfolio in Q2 2016.
- Blume Capital Management opened 17 new positions and closed 47 in Q2 2016.
- Blume Capital Management's portfolio value rose 4.7% quarter-over-quarter to $152M.
Based on Blume Capital Management's 13F filing for Q2 2016, filed 4 Aug 2016.